TRAIL-mediated apoptosis

Siddiqui IA, Malik A, Adhami YM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H. 2008. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with... [Pg.182]

Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K (2005) Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24 3532-3542 Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R, Shi Y (2003) Mechanism of XlAP-mediated inhibition of caspase-9. Mol Cell 11 519-527... [Pg.45]

M. A. De Esposti, W. C. Dougall, P. J. Smolak, J. Y. Wau, C. A. Smith, and R. G. Goodwin. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity, 1, (6), 813-820, 1997. [Pg.246]

Huang Y Erdmann N, Peng H, Herek S, Davis JS, Luo X, Ikezu T, Zheng J (2006) TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the iirlribitioir of Akt-1 phosphorylation. J Immiurol 177 2304—2313. [Pg.200]

Sayers TJ, Brooks AD, Koh CY, Ma W, Seki N, Raziuddin A, Blazar BR, Zhang X, Elliott PJ, Murphy WJ. The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood 2003 102 303-310. [Pg.178]

Psahoulia FH, Drosopoulos KG, Doubravska L, Andera L, Pintzas A (2007) Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 6 2591-2599... [Pg.2252]

Huerta-Yepez, S., Vega, M., Jazirehi, A., Garban, H., Kongo, R, Cheng, G., and Bonavida, B. (2004). Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Oncogene 23(29), 4993-5003. [Pg.54]

Ng, C.R, Zisman, A., and Bonavida, B. (2002). Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells role of XIAP in resistance. Prostate 53. 286-299. [Pg.476]

Zisman, A., Ng, C.R., Rantuck, A.J., Bonavida, B., and Belldegrun, A.S. (2001). Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis. J. Immunother. 24, 459-471. [Pg.478]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...